{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:28Z","timestamp":1792097368544,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03407-2","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:04:21Z","timestamp":1789452261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overcoming cordycepin limitations with SLNs-based nanoformulation: formulation development and cytotoxicity evaluation against human breast cancer cells"],"prefix":"10.1007","volume":"43","author":[{"given":"Saumyadeep","family":"Bora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Amirthalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Jodha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Pooja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Kulhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"3407_CR1","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1007\/s00210-024-03082-y","volume":"397","author":"S Bourang","year":"2024","unstructured":"Bourang S, Noruzpour M, Jahanbakhsh Godekahriz S, Ebrahimi HAC, Amani A, Asghari Zakaria R, Yaghoubi H. Application of nanoparticles in breast cancer treatment: a systematic review, Naunyn. Schmiedebergs Arch Pharmacol. 2024;397:6459\u2013505. https:\/\/doi.org\/10.1007\/s00210-024-03082-y.","journal-title":"Schmiedebergs Arch Pharmacol"},{"key":"3407_CR2","unstructured":"World Health Statistics. 2023: Monitoring health for the SDGs, Sustainable Development Goals, Geneva: World Health Organization, 2023. https:\/\/cdn.who.int\/media\/docs\/default-source\/gho-documents\/world-health-statistic-reports\/2023\/world-health-statistics-2023_20230519_.pdf"},{"key":"3407_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"Cancer J Clin"},{"key":"3407_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mpmed.2019.11.009","volume":"48","author":"S Chopra","year":"2020","unstructured":"Chopra S, Davies EL. Breast cancer. Med (Baltim). 2020;48:113\u20138. https:\/\/doi.org\/10.1016\/j.mpmed.2019.11.009.","journal-title":"Med (Baltim)"},{"key":"3407_CR5","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.3390\/cancers13246222","volume":"13","author":"V Shrihastini","year":"2021","unstructured":"Shrihastini V, Muthuramalingam P, Adarshan S, Sujitha M, Chen J-T, Shin H, Ramesh M. Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview. Cancers (Basel). 2021;13:6222. https:\/\/doi.org\/10.3390\/cancers13246222.","journal-title":"Cancers (Basel)"},{"key":"3407_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4110\/in.2009.9.3.98","volume":"9","author":"S Shin","year":"2009","unstructured":"Shin S, Lee S, Kwon J, Moon S, Lee S, Lee C-K, Cho K, Ha N-J, Kim K. Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Lipopolysaccharide-induced Inflammation in Macrophages. Immune Netw. 2009;9:98\u2013105. https:\/\/doi.org\/10.4110\/in.2009.9.3.98.","journal-title":"Immune Netw"},{"key":"3407_CR7","doi-asserted-by":"publisher","unstructured":"S.A. M., M.R. P., Antifungal Activity of 3\u2032-Deoxyadenosine (Cordycepin), Antimicrob. Agents Chemother 42 (1998) 1424\u20137. https:\/\/doi.org\/10.1128\/aac.42.6.1424","DOI":"10.1128\/aac.42.6.1424"},{"key":"3407_CR8","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1021\/bi00222a004","volume":"30","author":"WEG Mueller","year":"1991","unstructured":"Mueller WEG, Weiler BE, Charubala R, Pfleiderer W, Leserman L, Sobol RW, Suhadolnik RJ, Schroeder HC. Cordycepin analogs of 2\u2019,5\u2019-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase. Biochemistry. 1991;30:2027\u201333. https:\/\/doi.org\/10.1021\/bi00222a004.","journal-title":"Biochemistry"},{"key":"3407_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0014-2999(02)02359-2","volume":"453","author":"X Zhou","year":"2002","unstructured":"Zhou X, Meyer CU, Schmidtke P, Zepp F. Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells. Eur J Pharmacol. 2002;453:309\u201317. https:\/\/doi.org\/10.1016\/S0014-2999(02)02359-2.","journal-title":"Eur J Pharmacol"},{"key":"3407_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ol.2015.3273","volume":"10","author":"X Tian","year":"2015","unstructured":"Tian X, Li Y, Shen Y, Li Q, Wang Q, Feng L. Apoptosis and inhibition of proliferation of cancer cells induced by cordycepin (Review). Oncol Lett. 2015;10:595\u20139. https:\/\/doi.org\/10.3892\/ol.2015.3273.","journal-title":"Oncol Lett"},{"key":"3407_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-013-0121-9","volume":"4","author":"HS Tuli","year":"2014","unstructured":"Tuli HS, Sandhu SS, Sharma AK. Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin. 3 Biotech. 2014;4:1\u201312. https:\/\/doi.org\/10.1007\/s13205-013-0121-9.","journal-title":"3 Biotech"},{"key":"3407_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1515\/BC.2005.056","volume":"386","author":"H Thomadaki","year":"2005","unstructured":"Thomadaki H, Tsiapalis CM, Scorilas A. Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biol Chem. 2005;386:471\u201380. https:\/\/doi.org\/10.1515\/BC.2005.056.","journal-title":"Biol Chem"},{"key":"3407_CR13","doi-asserted-by":"publisher","unstructured":"Hsu P-Y, Lin Y-H, Yeh E-L, Lo H-C, Hsu T-H, Su C-C. Cordycepin and a preparation from Cordyceps militaris inhibit malignant transformation and proliferation by decreasing EGFR and IL-17RA signaling in a murine oral cancer model, Oncotarget; 8, 55 8 (2017) 93712. https:\/\/doi.org\/10.18632\/oncotarget.21477","DOI":"10.18632\/oncotarget.21477"},{"key":"3407_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.etap.2014.06.003","volume":"38","author":"HH Lee","year":"2014","unstructured":"Lee HH, Kim SO, Kim G-Y, Moon S-K, Kim W-J, Jeong YK, Yoo YH, Choi YH. Involvement of autophagy in cordycepin-induced apoptosis in human prostate carcinoma LNCaP cells. Environ Toxicol Pharmacol. 2014;38:239\u201350. https:\/\/doi.org\/10.1016\/j.etap.2014.06.003.","journal-title":"Environ Toxicol Pharmacol"},{"key":"3407_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3892\/ol.2016.4706","volume":"12","author":"L Shao","year":"2016","unstructured":"Shao L, Huang L, Yan S, Jin J, Ren S. Cordycepin induces apoptosis in human liver cancer HepG2 cells through extrinsic and intrinsic signaling pathways. Oncol Lett. 2016;12:995\u20131000. https:\/\/doi.org\/10.3892\/ol.2016.4706.","journal-title":"Oncol Lett"},{"key":"3407_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s11671-015-0851-1","volume":"10","author":"P Aramwit","year":"2015","unstructured":"Aramwit P, Porasuphatana S, Srichana T, Nakpheng T. Toxicity evaluation of cordycepin and its delivery system for sustained in vitro anti-lung cancer activity. Nanoscale Res Lett. 2015;10:152. https:\/\/doi.org\/10.1186\/s11671-015-0851-1.","journal-title":"Nanoscale Res Lett"},{"key":"3407_CR17","doi-asserted-by":"publisher","first-page":"1934578X1601100","DOI":"10.1177\/1934578X1601100119","volume":"11","author":"Y Di Wang","year":"2016","unstructured":"Di Wang Y, Zhang J, Lu Y, Wang J, Wang Q, Meng RJ, Lee D, Wang. Lesheng Teng, Cordycepin, a Natural Antineoplastic Agent, Induces Apoptosis of Breast Cancer Cells via Caspase-dependent Pathways. Nat Prod Commun. 2016;11:1934578X1601100119. https:\/\/doi.org\/10.1177\/1934578X1601100119.","journal-title":"Nat Prod Commun"},{"key":"3407_CR18","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3892\/ijo.2017.3862","volume":"50","author":"M Nasser Ide","year":"2017","unstructured":"Nasser Ide M, Masood M, Wei W, Li X, Zhou Y, Liu B, Li J, Li X. Cordycepin induces apoptosis in SGC\u20137901 cells through mitochondrial extrinsic phosphorylation of PI3K\/Akt by generating ROS. Int J Oncol. 2017;50:911\u20139. https:\/\/doi.org\/10.3892\/ijo.2017.3862.","journal-title":"Int J Oncol"},{"key":"3407_CR19","doi-asserted-by":"publisher","first-page":"111912","DOI":"10.18632\/oncotarget.22951","volume":"8","author":"C-W Wang","year":"2017","unstructured":"Wang C-W, Lee B-H, Tai C-J. The inhibition of cordycepin on cancer stemness in TGF-beta induced chemo-resistant ovarian cancer cell. Oncotarget. 2017;8:111912\u201321. https:\/\/doi.org\/10.18632\/oncotarget.22951.","journal-title":"Oncotarget"},{"key":"3407_CR20","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3892\/ol.2014.1965","volume":"7","author":"H Lu","year":"2014","unstructured":"Lu H, Li X, Zhang J, Shi H, Zhu X, He X. Effects of cordycepin on HepG2 and EA.hy926 cells: Potential antiproliferative, antimetastatic and anti\u2013angiogenic effects on hepatocellular carcinoma. Oncol Lett. 2014;7:1556\u201362. https:\/\/doi.org\/10.3892\/ol.2014.1965.","journal-title":"Oncol Lett"},{"key":"3407_CR21","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1021\/jf100269g","volume":"58","author":"Y-J Tsai","year":"2010","unstructured":"Tsai Y-J, Lin L-C, Tsai T-H. Pharmacokinetics of Adenosine and Cordycepin, a Bioactive Constituent of Cordyceps sinensis in Rat. J Agric Food Chem. 2010;58:4638\u201343. https:\/\/doi.org\/10.1021\/jf100269g.","journal-title":"J Agric Food Chem"},{"key":"3407_CR22","doi-asserted-by":"publisher","first-page":"e00121","DOI":"10.1002\/prp2.121","volume":"3","author":"G Li","year":"2015","unstructured":"Li G, Nakagome I, Hirono S, Itoh T, Fujiwara R. Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances. Pharmacol Res Perspect. 2015;3:e00121. https:\/\/doi.org\/10.1002\/prp2.121.","journal-title":"Pharmacol Res Perspect"},{"key":"3407_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jphs.2014.09.001","volume":"127","author":"K Nakamura","year":"2015","unstructured":"Nakamura K, Shinozuka K, Yoshikawa N. Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis. J Pharmacol Sci. 2015;127:53\u20136. https:\/\/doi.org\/10.1016\/j.jphs.2014.09.001.","journal-title":"J Pharmacol Sci"},{"key":"3407_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.arcmed.2009.10.012","volume":"41","author":"M Aghaei","year":"2010","unstructured":"Aghaei M, Karami-Tehrani F, Salami S, Atri M. Diagnostic Value of Adenosine Deaminase Activity in Benign and Malignant Breast Tumors. Arch Med Res. 2010;41:14\u20138. https:\/\/doi.org\/10.1016\/j.arcmed.2009.10.012.","journal-title":"Arch Med Res"},{"key":"3407_CR25","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3390\/pharmaceutics15061771","volume":"15","author":"J Suksiriworapong","year":"2023","unstructured":"Suksiriworapong J, Pongprasert N, Bunsupa S, Taresco V, Crucitti VC, Janurai T, Phruttiwanichakun P, Sakchaisri K, Wongrakpanich A. CD44-Targeted Lipid Polymer Hybrid Nanoparticles Enhance Anti-Breast Cancer Effect of Cordyceps militaris Extracts. Pharmaceutics. 2023;15:1771. https:\/\/doi.org\/10.3390\/pharmaceutics15061771.","journal-title":"Pharmaceutics"},{"key":"3407_CR26","doi-asserted-by":"publisher","first-page":"12225","DOI":"10.1021\/acs.jafc.3c03608","volume":"71","author":"J Jaiswal","year":"2023","unstructured":"Jaiswal J, Srivastav AK, Rajput PK, Yadav UCS, Kumar U. Integrating Synthesis, Physicochemical Characterization, and. J Agric Food Chem. 2023;71:12225\u201336. https:\/\/doi.org\/10.1021\/acs.jafc.3c03608. Silico Studies of Cordycepin-Loaded Bovine Serum Albumin Nanoparticles.","journal-title":"J Agric Food Chem"},{"key":"3407_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/NSA.S254770","volume":"13","author":"G Marslin","year":"2020","unstructured":"Marslin G, Khandelwal V, Franklin G. Cordycepin Nanoencapsulated in Poly(Lactic-Co-Glycolic Acid) Exhibits Better Cytotoxicity and Lower Hemotoxicity Than Free Drug. Nanotechnol Sci Appl. 2020;13:37\u201345. https:\/\/doi.org\/10.2147\/NSA.S254770.","journal-title":"Nanotechnol Sci Appl"},{"key":"3407_CR28","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s42452-025-07599-6","volume":"7","author":"S Sridhar","year":"2025","unstructured":"Sridhar S, Madhunapantula SRV, Ranganathan P, Velliyur Kanniappan G, Dugganaboyana GK. Enhanced in vitro anticancer activity of liposome-encapsulated nanocordycepin in breast and cervical cancer cells. Discov Appl Sci. 2025;7:1172. https:\/\/doi.org\/10.1007\/s42452-025-07599-6.","journal-title":"Discov Appl Sci"},{"key":"3407_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s11671-021-03489-z","volume":"16","author":"Z Yu","year":"2021","unstructured":"Yu Z, Gao L, Chen K, Zhang W, Zhang Q, Li Q, Hu K. Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment. Nanoscale Res Lett. 2021;16:88. https:\/\/doi.org\/10.1186\/s11671-021-03489-z.","journal-title":"Nanoscale Res Lett"},{"key":"3407_CR30","doi-asserted-by":"publisher","first-page":"130445","DOI":"10.1016\/j.colsurfa.2022.130445","volume":"656","author":"AK Jangid","year":"2023","unstructured":"Jangid AK, Solanki R, Jadav M, Bora S, Patel S, Pooja D, Kulhari H. Phenyl boronic acid -PEG-stearic acid biomaterial-based and sialic acid targeted nanomicelles for colon cancer treatment. Colloids Surf Physicochem Eng Asp. 2023;656:130445. https:\/\/doi.org\/10.1016\/j.colsurfa.2022.130445.","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"3407_CR31","doi-asserted-by":"publisher","first-page":"149660","DOI":"10.1016\/j.ijbiomac.2025.149660","volume":"338","author":"S Bora","year":"2026","unstructured":"Bora S, Priya B, Pooja D, Kulhari H. Gellan gum-based nanocarriers for the delivery of anticancer agents: A review. Int J Biol Macromol. 2026;338:149660. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149660.","journal-title":"Int J Biol Macromol"},{"key":"3407_CR32","doi-asserted-by":"publisher","unstructured":"Bora S, Medicherla K, Kulhari H, Pooja D. Fucoidan-based pharmaceutical formulations for the delivery of phytochemicals: A review. Int J Biol Macromol. 2025;149279. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149279.","DOI":"10.1016\/j.ijbiomac.2025.149279"},{"key":"3407_CR33","doi-asserted-by":"publisher","unstructured":"Bora S, Patel S, Sharma S, Pooja D, Kulhari H. Natural Polysaccharides for Designing Herbal Formulations. In: Singh A, Kulhari H, Saharan VA, editors. Formul. Pharma-, Nutra\u2010, Cosmeceutical Prod. from Herb. Subst. Wiley; 2025. pp. 119\u201337. https:\/\/doi.org\/10.1002\/9781119769484.ch4.","DOI":"10.1002\/9781119769484.ch4"},{"key":"3407_CR34","doi-asserted-by":"publisher","unstructured":"Bora S, Pooja D, Mutyala BR, Kulhari H. Applications of Carbon-Based Nanomaterials for the Delivery of Herbal Molecules. In: Singh A, Kulhari H, Saharan VA, editors. Formul. Pharma\u2010, Nutra\u2010, Cosmeceutical Prod. from Herb. Subst. Wiley; 2025. pp. 533\u201348. https:\/\/doi.org\/10.1002\/9781119769484.ch19.","DOI":"10.1002\/9781119769484.ch19"},{"key":"3407_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-981-99-5314-1_5","volume-title":"Nanotechnol. Based Deliv. Phytoconstituents Cosmeceuticals","author":"S Priyadarshini","year":"2024","unstructured":"Priyadarshini S, Bora S, Kulhari H. Lipid-Based Nanocarriers for the Delivery of Phytoconstituents. In: Pooja D, Kulhari H, editors. Nanotechnol. Based Deliv. Phytoconstituents Cosmeceuticals. Singapore: Springer Nature Singapore; 2024. pp. 125\u201367. https:\/\/doi.org\/10.1007\/978-981-99-5314-1_5."},{"key":"3407_CR36","doi-asserted-by":"publisher","unstructured":"Bora S, Pooja D, Kulhari H. Applications of Surface Modified Carbon Nanotubes in Drug Delivery, in: J. Aslam, C.M. Hussain, R. Aslam, editors, Surf. Modif. Carbon Nanotub. Vol. 2 Ind. Appl., American Chemical Society, 2022: pp. 19\u201346. https:\/\/doi.org\/10.1021\/bk-2022-1425.ch002","DOI":"10.1021\/bk-2022-1425.ch002"},{"key":"3407_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.15171\/apb.2016.021","volume":"6","author":"L Azhar Shekoufeh Bahari","year":"2016","unstructured":"Azhar Shekoufeh Bahari L, Hamishehkar H. The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature Review. Adv Pharm Bull. 2016;6:143\u201351. https:\/\/doi.org\/10.15171\/apb.2016.021.","journal-title":"Adv Pharm Bull"},{"key":"3407_CR38","doi-asserted-by":"publisher","first-page":"104709","DOI":"10.1016\/j.jddst.2023.104709","volume":"86","author":"M Akanda","year":"2023","unstructured":"Akanda M, Mithu MSH, Douroumis D. Solid lipid nanoparticles: An effective lipid-based technology for cancer treatment. J Drug Deliv Sci Technol. 2023;86:104709. https:\/\/doi.org\/10.1016\/j.jddst.2023.104709.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3407_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.15171\/apb.2016.06","volume":"6","author":"Z Mardhiah Adib","year":"2016","unstructured":"Mardhiah Adib Z, Ghanbarzadeh S, Kouhsoltani M, Yari Khosroshahi A, Hamishehkar H. The Effect of Particle Size on the Deposition of Solid Lipid Nanoparticles in Different Skin Layers: A Histological Study. Adv Pharm Bull. 2016;6:31\u20136. https:\/\/doi.org\/10.15171\/apb.2016.06.","journal-title":"Adv Pharm Bull"},{"key":"3407_CR40","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","volume":"68","author":"M Geszke-Moritz","year":"2016","unstructured":"Geszke-Moritz M, Moritz M. Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies. Mater Sci Eng C. 2016;68:982\u201394. https:\/\/doi.org\/10.1016\/j.msec.2016.05.119.","journal-title":"Mater Sci Eng C"},{"key":"3407_CR41","doi-asserted-by":"publisher","first-page":"26777","DOI":"10.1039\/d0ra03491f","volume":"10","author":"Y Duan","year":"2020","unstructured":"Duan Y, Dhar A, Patel C, Khimani M, Neogi S, Sharma P, Siva Kumar N, Vekariya RL. A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems. RSC Adv. 2020;10:26777\u201391. https:\/\/doi.org\/10.1039\/d0ra03491f.","journal-title":"RSC Adv"},{"key":"3407_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH M\u00fcller","year":"2000","unstructured":"M\u00fcller RH, M\u00e4der K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161\u201377. https:\/\/doi.org\/10.1016\/S0939-6411(00)00087-4.","journal-title":"Eur J Pharm Biopharm"},{"key":"3407_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/1735-5362.235156","volume":"13","author":"P Ghasemiyeh","year":"2018","unstructured":"Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages. Res Pharm Sci. 2018;13:288\u2013303. https:\/\/doi.org\/10.4103\/1735-5362.235156.","journal-title":"Res Pharm Sci"},{"key":"3407_CR44","doi-asserted-by":"publisher","DOI":"10.1039\/D6PM00179C","author":"S Bora","year":"2026","unstructured":"Bora S, Jodha B, Vidap R, Patel S, Pooja D, Kulhari H. Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cells. RSC Pharm. 2026. https:\/\/doi.org\/10.1039\/D6PM00179C.","journal-title":"RSC Pharm"},{"key":"3407_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.chemphyslip.2016.05.006","volume":"198","author":"R Radhakrishnan","year":"2016","unstructured":"Radhakrishnan R, Kulhari H, Pooja D, Gudem S, Bhargava S, Shukla R, Sistla R. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chem Phys Lipids. 2016;198:51\u201360. https:\/\/doi.org\/10.1016\/j.chemphyslip.2016.05.006.","journal-title":"Chem Phys Lipids"},{"key":"3407_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.carres.2015.01.005","volume":"406","author":"J-Q Zhang","year":"2015","unstructured":"Zhang J-Q, Wu D, Jiang K-M, Zhang D, Zheng X, Wan C-P, Zhu H-Y, Xie X-G, Jin Y, Lin J. Preparation, spectroscopy and molecular modelling studies of the inclusion complex of cordycepin with cyclodextrins. Carbohydr Res. 2015;406:55\u201364. https:\/\/doi.org\/10.1016\/j.carres.2015.01.005.","journal-title":"Carbohydr Res"},{"key":"3407_CR47","doi-asserted-by":"publisher","first-page":"49122","DOI":"10.1039\/C5RA03316K","volume":"5","author":"D Pooja","year":"2015","unstructured":"Pooja D, Kulhari H, Tunki L, Chinde S, Kuncha M, Grover P, Rachamalla SS, Sistla R. Nanomedicines for targeted delivery of etoposide to non-small cell lung cancer using transferrin functionalized nanoparticles. RSC Adv. 2015;5:49122\u201331. https:\/\/doi.org\/10.1039\/C5RA03316K.","journal-title":"RSC Adv"},{"key":"3407_CR48","doi-asserted-by":"publisher","first-page":"104988","DOI":"10.1016\/j.chemphyslip.2020.104988","volume":"233","author":"S Karamchedu","year":"2020","unstructured":"Karamchedu S, Tunki L, Kulhari H, Pooja D. Morin hydrate loaded solid lipid nanoparticles: Characterization, stability, anticancer activity, and bioavailability. Chem Phys Lipids. 2020;233:104988. https:\/\/doi.org\/10.1016\/j.chemphyslip.2020.104988.","journal-title":"Chem Phys Lipids"},{"key":"3407_CR49","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK-M, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D\u2019Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin K-M, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, Garc\u00eda-S\u00e1ez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, J\u00e4\u00e4ttel\u00e4 M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, L\u00f3pez-Ot\u00edn C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine J-C, Martin SJ, Martinou J-C, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Mu\u00f1oz-Pinedo C, Nagata S, Nu\u00f1ez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon H-U, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4.","journal-title":"Cell Death Differ"},{"key":"3407_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.toxlet.2012.10.008","volume":"215","author":"P Elumalai","year":"2012","unstructured":"Elumalai P, Gunadharini DN, Senthilkumar K, Banudevi S, Arunkumar R, Benson CS, Sharmila G, Arunakaran J. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway. Toxicol Lett. 2012;215:131\u201342. https:\/\/doi.org\/10.1016\/j.toxlet.2012.10.008.","journal-title":"Toxicol Lett"},{"key":"3407_CR51","doi-asserted-by":"publisher","unstructured":"Yuan L, Cai Y, Zhang L, Liu S, Li P, Li X. Promoting Apoptosis, a Promising Way to Treat Breast Cancer With Natural Products: A Comprehensive Review. Front Pharmacol. 2022;12. https:\/\/doi.org\/10.3389\/fphar.2021.801662.","DOI":"10.3389\/fphar.2021.801662"},{"key":"3407_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.taap.2011.08.030","volume":"257","author":"S Choi","year":"2011","unstructured":"Choi S, Lim M-H, Kim KM, Jeon BH, Song WO, Kim TW. Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor. Toxicol Appl Pharmacol. 2011;257:165\u201373. https:\/\/doi.org\/10.1016\/j.taap.2011.08.030.","journal-title":"Toxicol Appl Pharmacol"},{"key":"3407_CR53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijpharm.2012.03.032","volume":"430","author":"S Martins","year":"2012","unstructured":"Martins S, Costa-Lima S, Carneiro T, Cordeiro-da-Silva A, Souto EB, Ferreira DC. Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway. Int J Pharm. 2012;430:216\u201327. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.03.032.","journal-title":"Int J Pharm"},{"key":"3407_CR54","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/1873-3468.15046","volume":"599","author":"S Lawrence","year":"2025","unstructured":"Lawrence S, Lin J, Khurshid A, Utami W, Singhania R, Ashraf S, Thorn GJ, Mangangcha IR, Spriggs K, Kim D-H, Barrett D, de Moor CH. Cordycepin generally inhibits growth factor signal transduction in a systems pharmacology study. FEBS Lett. 2025;599:415\u201335. https:\/\/doi.org\/10.1002\/1873-3468.15046.","journal-title":"FEBS Lett"},{"key":"3407_CR55","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/biom9090414","volume":"9","author":"D Lee","year":"2019","unstructured":"Lee D, Lee W-Y, Jung K, Kwon YS, Kim D, Hwang GS, Kim C-E, Lee S, Kang KS. The Inhibitory Effect of Cordycepin on the Proliferation of MCF-7 Breast Cancer Cells, and Its Mechanism: An Investigation Using Network Pharmacology-Based Analysis. Biomolecules. 2019;9:414. https:\/\/doi.org\/10.3390\/biom9090414.","journal-title":"Biomolecules"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03407-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03407-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03407-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:40Z","timestamp":1792096900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03407-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3407"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03407-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"290"}}